RT Journal Article
SR Electronic
T1 Cannabinoids and glaucoma
JF British Journal of Ophthalmology
JO Br J Ophthalmol
FD BMJ Publishing Group Ltd.
SP 708
OP 713
DO 10.1136/bjo.2003.032250
VO 88
IS 5
A1 I Tomida
A1 R G Pertwee
A1 A Azuara-Blanco
YR 2004
UL http://bjo.bmj.com/content/88/5/708.abstract
AB Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.